Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 4/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | CDC7 | O00311 | 1/20 | 0.41 |
| ▸ | STK17B | O94768 | 2/20 | 0.40 |
| ▸ | STK17A | Q9UEE5 | 2/20 | 0.40 |
| ▸ | CAMKK1 | Q8N5S9 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | JAK3 | P52333 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.40 |
| ▸ | CHUK | O15111 | 1/20 | 0.40 |
| ▸ | IKBKG | Q9Y6K9 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2877899 | 0.86 | KDM4E (0.56) | IKBKBCYP19A1PLAUCDC7STK17B | |
| SCHEMBL2880255 | 0.85 | KDM4E (0.54) | IKBKBCYP19A1PLAUCDC7STK17B | |
| SCHEMBL31661936 | 0.85 | IKBKB (0.52) | IKBKBCYP19A1PLAUCDC7JAK2 | |
| SCHEMBL29986368 | 0.77 | CYP19A1 (0.48) | IKBKBCYP19A1PLAUAPPCKS1B | |
| SCHEMBL15260648 | 0.75 | CYP19A1 (0.49) | IKBKBCYP19A1PLAUAPPCA1 | |
| SCHEMBL2875320 | 0.74 | ERN1 (0.48) | CYP19A1APPCA1CA2CA9 | |
| SCHEMBL29177680 | 0.74 | CYP19A1 (0.48) | IKBKBCYP19A1PLAUAPPCA1 | |
| SCHEMBL28401036 | 0.74 | CYP19A1 (0.48) | IKBKBCYP19A1PLAUCDC7APP | |
| SCHEMBL28537163 | 0.73 | IKBKB (0.40) | IKBKBCYP19A1PLAUCDC7STK17B | |
| SCHEMBL28579081 | 0.73 | CYP19A1 (0.43) | IKBKBCYP19A1CDC7STK17BSTK17A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | claimed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | claimed |
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | DNM1, FIS1, DCUN1D1 | IKBKB 4609/4885CYP19A1 3384/4885PLAU 1565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.